Form 4 for TYRA Tyra Biosciences, Inc.

Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-06 · accession 0000895345-24-000035 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2024-02-08	2024-02-06	TYRA	Boxer Capital, LLC	See Remarks	A - Grant	$13.01	+63.4K	85.9K	+281%	+$825.0K
D	2024-02-08	2024-02-06	TYRA	Boxer Capital, LLC	See Remarks	A - Grant	$13.01	+705.3K	705.3K	New	+$9.18M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-06	A	A	63,412	$13.01	85,939	I See Footnote	—	—	(F1) These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
2	Derivative	Warrant (right to purchase)	2024-02-06	A	A	705,280	$13.01	705,280	D	$0.00 · — to —	705,280 Common Stock	(F2) These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). Boxer Asset Management Inc. ("Boxer Management") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any. (F3) These Warrants are exercisable immediately (subject to any applicable beneficial ownership limitation) and do not have an expiration date.